Porcine Epidemic Diarrhea Vaccines Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the porcine epidemic diarrhea vaccines market size evolved in recent years?
The market size of vaccines for porcine epidemic diarrhea has seen robust growth in the past few years. It is projected to expand from $1.67 billion in 2024 to $1.8 billion in 2025, with a compound annual growth rate (CAGR) of 8.0%. The historic period growth is largely owed to extensive vaccination drives, broadened immunization programs, the use of disposable syringes, efforts to eliminate diarrhea, and initiatives such as the Global Alliance for Vaccines and Immunization (GAVI).
What are the predictions for the porcine epidemic diarrhea vaccines market size in the coming years?
The porcine epidemic diarrhea vaccines market size is expected to see strong growth in the next few years. It will grow to $2.42 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to the growing emphasis on immunization programs, expanded vaccine development pipelines, expanding pig populations, focus on cold chain management, and rising awareness about the importance of preventive healthcare measures. Major trends in the forecast period include continued innovations in vaccine delivery device technology, focus on needle-free solutions, advancements in personalized medicine, growing preference for self-administered vaccines, and strengthening animal healthcare infrastructure and distribution networks.
Get your porcine epidemic diarrhea vaccines market report here!
What key factors are fueling the growth of the porcine epidemic diarrhea vaccines market?
Anticipated advancements in the porcine epidemic diarrhea vaccine market can be attributed to the rise in pig farming. This particular farming process, which involves breeding, nurturing, and managing domestic pigs from birth until they’re ready for sale, as well as marketing and selling pork products, is seeing a surge due to several factors. The key factors behind this surge involve an augmented worldwide demand for pork products, refined breeding and management tactics, advances in farming procedures, and expansion of pork consumption markets. Porcine epidemic diarrhea (PED) vaccines play a crucial role in pig farming by controlling and preventing possible disease outbreaks. These vaccines are typically given either orally or via injection during the sow’s gestation period, which provides passive immunity to the newborn piglets via colostrum. A concrete example of this growth is that the pork production in the United States reached 40.6 billion pounds in 2022, according to the United States Department of Agriculture, representing a 1 percent increase from the previous year. Therefore, it’s expected that the surge in pig farming will further fuel the growth of the porcine epidemic diarrhea vaccine market.
How is the global porcine epidemic diarrhea vaccines market divided into key segments?
The porcine epidemic diarrhea vaccines market covered in this report is segmented –
1) By Product: Live Vaccines, Killed Vaccines
2) By Application: Piglets, Adults Pigs
3) By End-User: Veterinary Hospitals, Hog Production Farms
Subsegments:
1) By Live Vaccines: Oral Live Vaccines, Injectable Live Vaccines
2) By Killed Vaccines: Inactivated Injectable Vaccines, Inactivated Oral Vaccines
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16514&type=smp
Who are the key firms paving the way for growth in the porcine epidemic diarrhea vaccines market?
Major companies operating in the porcine epidemic diarrhea vaccines market are Zoetis Inc., Merck Animal Health, Elanco Animal Health, Idexx Laboratories Inc., Bio-Rad Laboratories Inc., Ceva Santé Animale Health Company, Phibro Animal Health Corporation, Benchmark Animal Health Ltd., IDT Biologika GmbH, Vaxxinova, Qilu Animal Health Products Factory Co. Ltd., Tecnovax, Green Cross Veterinary Products Co. Ltd., Nisseiken Co. Ltd., Komipharm International Co. Ltd., Boehringer Ingelheim Animal Health, MSD Animal Health, Ourofino Saúde Animal, Medgene Labs, Harrisvaccines Inc
What key trends are currently impacting the porcine epidemic diarrhea vaccines market’s development?
Leading firms in the porcine epidemic diarrhea vaccines market are advancing their market position through the creation of novel products like the porcine parvovirus (PPV) vaccine. Designed as a veterinary immunization, the PPV vaccine aims to combat reproductive issues in pigs linked to PPV, a non-enveloped virus causing infertility, stillbirth, mummified fetuses, and frail piglets. Boehringer Ingelheim, a pharmaceutical company based in Germany, debuted the ReproCyc ParvoFLEX porcine parvovirus (PPV) vaccine in March 2022. This ground-breaking vaccine is formulated to fight against reproductive problems in pigs such as infertility, stillbirths, mummified fetuses, and weak piglets, all caused by PPV, a small, non-enveloped virus. The notable innovation of this product release is in the vaccine’s advanced composition and effectiveness, delivering wide-ranging protection against PPV-related reproductive harm and, therefore, protecting the health and yield of pig populations.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16514
What regions are contributing significantly to the growth of the porcine epidemic diarrhea vaccines market?
Asia-Pacific was the largest region in the porcine epidemic diarrhea vaccines market in 2024. The regions covered in the porcine epidemic diarrhea vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Cancer Vaccines Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report
Veterinary Vaccines Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report
Companion Animal Veterinary Vaccines Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
